EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis

Alicia Sanmartín-Sánchez iD, Rocío Fernández-Jiménez iD, Josefina Olivares-Alcolea, Eva Cabrera-César, Francisco Espíldora-Hernández, Isabel Vegas-Aguilar, María Del Mar Amaya-Campos, Víctor José Simón-Frapolli iD, María Villaplana-García, Isabel Cornejo-Pareja iD, Ana Sánchez-García, Mora Murri iD und 6 weitere

Nutrients · 2025

DOI: 10.3390/nu17172739 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, 2025. Verfasst von Alicia Sanmartín-Sánchez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Son Espases University Hospital, 07120 Mallorca, Spain. Hauptthemen laut MEDLINE: Cachexia, Growth Differentiation Factor 15, Idiopathic Pulmonary Fibrosis, Mitochondria. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objetives: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with poor prognosis. Nutritional disorders, particularly cachexia, significantly impact morbidity and mortality in IPF but remain under-investigated. This study aimed to characterize cachexia phenotypes in IPF through morphofunctional assessment (MFA) and to evaluate their prognostic relevance, including the role of mitochondrial biomarkers.

Methods

In this prospective bicenter study, 85 IPF patients underwent MFA including bioelectrical impedance vector analysis (BIVA), nutritional ultrasound (NU), and T12-level computed tomography (T12-CT) for body composition. Functional and strength assessments included timed up and go test (TUG) and handgrip strength (HGS), respectively. Cachexia was defined by Evans’ criteria, Martin’s CT-based criteria, and our IPF-specific proposed definition. Serum GDF-15 and PGC-1α levels were also measured.

Results

Cachexia prevalence varied by definition: 24.71% (Evans), 29.5% (Martin) and 42.4% (IPF Cachexia Syndrome). Cachectic patients showed significantly lower muscle mass, function, and quality (measured by reduced muscle attenuation at T12-CT), along with higher GDF-15 and lower PGC-1α levels. The presence of IPF Cachexia syndrome (HR 2.56; 95% CI, 1.08–6.07; p = 0.033), GDF-15 > 4412.0 pg/mL (HR 3.21; 95% CI, 1.04–9.90; p = 0.042) and impaired TUG (>8 s) (HR 3.77; 95% CI, 1.63–8.71; 0.002) were all independently associated with increased 24-month mortality.

Conclusions

Cachexia is prevalent in IPF and showed strong concordance between the three diagnostic criteria. The IPF Cachexia syndrome, based on comprehensive morphofunctional phenotyping, demonstrated superior discriminatory capacity. The addition of mitochondrial biomarkers may improve early detection and support personalized interventions to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaGrowth Differentiation Factor 15Idiopathic Pulmonary FibrosisMitochondriaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAgedFemaleHumansMaleMiddle AgedBiomarkersBody CompositionHand StrengthPhenotypePrognosisProspective Studies

Stichwörter der Autor:innen

GDF-15PGC-1αbody compositioncachexiachronic pulmonary diseasesidiopathic pulmonary fibrosismalnutritionmorphofunctional assessmentmyosteatosissarcopenia

Substanzen

BiomarkersGDF15 protein, humanGrowth Differentiation Factor 15Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Son Espases University Hospital, 07120 Mallorca, Spain.
  • Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Malaga, Spain.
  • Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Malaga, Spain.
  • Department of Medicine and Dermatology, Málaga University, 29016 Malaga, Spain.
  • Department of Endocrinology and Nutrition, Quironsalud Málaga Hospital, Av. Imperio Argentina, 29004 Malaga, Spain.
  • Department of Neumology, Virgen de la Victoria University Hospital, 29010 Malaga, Spain.

ORCID-Profile: Alicia Sanmartín-Sánchez, Rocío Fernández-Jiménez, Víctor José Simón-Frapolli, Isabel Cornejo-Pareja, Mora Murri, Patricia Guirado-Peláez, Álvaro Vidal-Suárez, Jose Manuel García-Almeida

Zitieren

APA

Sanmartín-Sánchez, A., Fernández-Jiménez, R., Olivares-Alcolea, J., Cabrera-César, E., Espíldora-Hernández, F., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Simón-Frapolli, V. J., Villaplana-García, M., Cornejo-Pareja, I., Sánchez-García, A., Murri, M., Guirado-Peláez, P., Vidal-Suárez, Á., Garrido-Sánchez, L., Tinahones, F. J., Velasco-Garrido, J. L., & García-Almeida, J. M. (2025). Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis. Nutrients. https://doi.org/10.3390/nu17172739

Vancouver

Sanmartín-Sánchez A, Fernández-Jiménez R, Olivares-Alcolea J, Cabrera-César E, Espíldora-Hernández F, Vegas-Aguilar I, et al. Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis. Nutrients. 2025. doi:10.3390/nu17172739

BibTeX
@article{SanmartnSnchez2025,
  author = {Sanmartín-Sánchez, Alicia and Fernández-Jiménez, Rocío and Olivares-Alcolea, Josefina and Cabrera-César, Eva and Espíldora-Hernández, Francisco and Vegas-Aguilar, Isabel and Amaya-Campos, María Del Mar and Simón-Frapolli, Víctor José and Villaplana-García, María and Cornejo-Pareja, Isabel and Sánchez-García, Ana and Murri, Mora and Guirado-Peláez, Patricia and Vidal-Suárez, Álvaro and Garrido-Sánchez, Lourdes and Tinahones, Francisco J and Velasco-Garrido, Jose Luis and García-Almeida, Jose Manuel},
  title = {Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17172739}
}
Kostenlos starten →